FD274

Modify Date: 2024-01-06 13:45:50

FD274 Structure
FD274 structure
Common Name FD274
CAS Number 2641899-38-7 Molecular Weight 480.90
Density N/A Boiling Point N/A
Molecular Formula C22H14ClFN6O2S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of FD274


FD274 is a highly potent PI3K/mTOR dual inhibitor with IC50s of 0.65 nM, 1.57 nM, 0.65 nM, 0.42 nM, and 2.03 nM against PI3Kα/β/γ/δ and mTOR, respectively. FD274 exhibits significant anti-proliferation of AML cell lines (HL-60 and MOLM-16). FD274 demonstrates dose-dependent inhibition of tumor growth in the HL-60 xenograft model. FD274 has the potential for acute myeloid leukemia research[1].

 Names

Name FD274

 FD274 Biological Activity

Description FD274 is a highly potent PI3K/mTOR dual inhibitor with IC50s of 0.65 nM, 1.57 nM, 0.65 nM, 0.42 nM, and 2.03 nM against PI3Kα/β/γ/δ and mTOR, respectively. FD274 exhibits significant anti-proliferation of AML cell lines (HL-60 and MOLM-16). FD274 demonstrates dose-dependent inhibition of tumor growth in the HL-60 xenograft model. FD274 has the potential for acute myeloid leukemia research[1].
Related Catalog
Target

PI3Kα:0.65 nM (IC50)

PI3Kβ:1.57 nM (IC50)

PI3Kδ:0.65 nM (IC50)

PI3Kγ:0.42 nM (IC50)

mTOR:2.03 nM (IC50)

References

[1]. Chengbin Yang, et al. Discovery of N-(2-chloro-5-(3-(pyridin-4-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide (FD274) as a highly potent PI3K/mTOR dual inhibitor for the treatment of acute myeloid leukemia. Eur J Med Chem. 2023 Oct 5;258:115543.  

 Chemical & Physical Properties

Molecular Formula C22H14ClFN6O2S
Molecular Weight 480.90
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.